SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Regeneron Pharmaceuticals, Inc. Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA(TM) (aflibercept) Injection